StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SPRBBearishEarningsnews
Materiality pending

Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates

May 13, 2024, 6:18 PM EDT1 sourcesAI-analyzed

AI summary

What happened, with direct paths to the underlying reporting

- SPRB reported quarterly loss of $0.28 per share, beating estimates and showing growth. - Revenues for SPRB of $2 million exceeded estimates by 79.55%. - Shares of SPRB have declined 71.6% year-to-date compared to S&P 500's gain. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

  • SPRB reported quarterly loss of $0.28 per share, beating estimates and showing growth.
  • Revenues for SPRB of $2 million exceeded estimates by 79.55%.
  • Shares of SPRB have declined 71.6% year-to-date compared to S&P 500's gain.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.